![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 20184 |
FusionGeneSummary for LRPAP1_HNRNPM |
![]() |
Fusion gene information | Fusion gene name: LRPAP1_HNRNPM | Fusion gene ID: 20184 | Hgene | Tgene | Gene symbol | LRPAP1 | HNRNPM | Gene ID | 4043 | 4670 |
Gene name | LDL receptor related protein associated protein 1 | heterogeneous nuclear ribonucleoprotein M | |
Synonyms | A2MRAP|A2RAP|HBP44|MRAP|MYP23|RAP|alpha-2-MRAP | CEAR|HNRNPM4|HNRPM|HNRPM4|HTGR1|NAGR1|hnRNP M | |
Cytomap | 4p16.3 | 19p13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | alpha-2-macroglobulin receptor-associated protein39 kDa receptor-associated proteinlow density lipoprotein receptor-related protein associated protein 1low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associa | heterogeneous nuclear ribonucleoprotein MCEA receptorN-acetylglucosamine receptor 1heterogenous nuclear ribonucleoprotein M4hnRNA-binding protein M4 | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | P30533 | P52272 | |
Ensembl transtripts involved in fusion gene | ENST00000500728, ENST00000296325, | ENST00000348943, ENST00000325495, ENST00000602219, | |
Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 12 X 13 X 4=624 |
# samples | 3 | 14 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(14/624*10)=-2.15611920191728 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LRPAP1 [Title/Abstract] AND HNRNPM [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LRPAP1 | GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 8083232 |
Hgene | LRPAP1 | GO:0032091 | negative regulation of protein binding | 8083232 |
Hgene | LRPAP1 | GO:0048259 | regulation of receptor-mediated endocytosis | 7774585 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AL046867 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000500728 | ENST00000348943 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
intron-3CDS | ENST00000500728 | ENST00000325495 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
intron-intron | ENST00000500728 | ENST00000602219 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
intron-3CDS | ENST00000296325 | ENST00000348943 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
intron-3CDS | ENST00000296325 | ENST00000325495 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
intron-intron | ENST00000296325 | ENST00000602219 | LRPAP1 | chr4 | 3514690 | - | HNRNPM | chr19 | 8551251 | + |
Top |
FusionProtFeatures for LRPAP1_HNRNPM |
![]() |
Hgene | Tgene |
LRPAP1 | HNRNPM |
Molecular chaperone for LDL receptor-related proteinsthat may regulate their ligand binding activity along thesecretory pathway. {ECO:0000269|PubMed:7774585}. | Pre-mRNA binding protein in vivo, binds avidly topoly(G) and poly(U) RNA homopolymers in vitro. Involved insplicing. Acts as a receptor for carcinoembryonic antigen inKupffer cells, may initiate a series of signaling events leadingto tyrosine phosphorylation of proteins and induction of IL-1alpha, IL-6, IL-10 and tumor necrosis factor alpha cytokines. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LRPAP1_HNRNPM |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LRPAP1_HNRNPM |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LRPAP1_HNRNPM |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LRPAP1_HNRNPM |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |